November 12, 2012

BUMMER: Malaria Vaccine Candidate Gives Disappointing Results. “Three shots of the vaccine, known as RTS, S or Mosquirix and produced by GlaxoSmithKline, gave babies fewer than 12 weeks old 31 percent protection against detectable malaria and 37 percent protection against severe malaria, according to an announcement by the company at a vaccines conference in Cape Town.”

Comments are closed.